Replimune Group, Inc. — Director's Dealing 2020

Jul 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-07-20

Reporting Person: Pirzkall Andrea (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-20	Employee Stock Option (right to buy)	$22.45	A	300000	Acquired	2030-07-20	Common Stock (300000)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on July 20, 2021 and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.